Kerry Cooper

1.4k total citations
39 papers, 943 citations indexed

About

Kerry Cooper is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Kerry Cooper has authored 39 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Nephrology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Kerry Cooper's work include Parathyroid Disorders and Treatments (23 papers), Dialysis and Renal Disease Management (10 papers) and Vitamin D Research Studies (8 papers). Kerry Cooper is often cited by papers focused on Parathyroid Disorders and Treatments (23 papers), Dialysis and Renal Disease Management (10 papers) and Vitamin D Research Studies (8 papers). Kerry Cooper collaborates with scholars based in United States, Canada and United Kingdom. Kerry Cooper's co-authors include David H. Evans, William G. Goodman, James B. Wetmore, Konstantin Gurevich, Stuart M. Sprague, John Buerkert, Maureen Reiner, Brian D. Bradbury, Norman J. Siegel and Karen M. Gaudio and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Kerry Cooper

38 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerry Cooper United States 17 631 176 172 167 142 39 943
B Hory France 12 492 0.8× 155 0.9× 121 0.7× 97 0.6× 130 0.9× 43 757
Ana Carina Ferreira Portugal 13 419 0.7× 225 1.3× 142 0.8× 88 0.5× 195 1.4× 61 875
Daniela Sardella Italy 19 751 1.2× 253 1.4× 144 0.8× 180 1.1× 164 1.2× 34 1.1k
Carolyn Griffith United States 7 839 1.3× 181 1.0× 154 0.9× 147 0.9× 189 1.3× 8 1.1k
Lucie Desjardins France 12 452 0.7× 82 0.5× 123 0.7× 63 0.4× 80 0.6× 14 700
Kenichi Satomura Japan 20 264 0.4× 150 0.9× 108 0.6× 101 0.6× 107 0.8× 50 890
Ichiro Ohkido Japan 16 673 1.1× 157 0.9× 154 0.9× 174 1.0× 273 1.9× 90 1.1k
Shohei Nakanishi Japan 16 750 1.2× 216 1.2× 227 1.3× 120 0.7× 245 1.7× 31 986
Michael M. Friedlaender Israel 16 284 0.5× 140 0.8× 131 0.8× 160 1.0× 132 0.9× 47 928
Peter Jehle Germany 20 292 0.5× 65 0.4× 344 2.0× 150 0.9× 65 0.5× 54 1.2k

Countries citing papers authored by Kerry Cooper

Since Specialization
Citations

This map shows the geographic impact of Kerry Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Cooper more than expected).

Fields of papers citing papers by Kerry Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Cooper. The network helps show where Kerry Cooper may publish in the future.

Co-authorship network of co-authors of Kerry Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry Cooper. A scholar is included among the top collaborators of Kerry Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry Cooper. Kerry Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barratt, Jonathan, Sean J. Barbour, Robert Brenner, et al.. (2024). Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy. Journal of the American Society of Nephrology. 36(4). 679–687. 15 indexed citations
2.
Barratt, Jonathan, Sean Barbour, Robert Brenner, et al.. (2024). Long-Term Results from the ORIGIN Phase 2b Study of Atacicept for the Treatment of IgA Nephropathy (IgAN). Journal of the American Society of Nephrology. 35(10S). 1 indexed citations
3.
Hsiung, Jui‐Ting, et al.. (2023). Liver Disease Is a Risk Factor for Recurrent Hyperkalemia: A Retrospective Cohort Study. Journal of Clinical Medicine. 12(14). 4562–4562.
4.
Cunningham, John, Geoffrey A. Block, Glenn M. Chertow, et al.. (2019). Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients. Kidney International Reports. 4(7). 987–994. 11 indexed citations
5.
Levy, Adrian R., Shan Xing, Steven M. Brunelli, et al.. (2019). Symptoms of Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: A Prospective Cohort Study. American Journal of Kidney Diseases. 75(3). 373–383. 14 indexed citations
6.
Lozano‐Ortega, Greta, Nathalie Waser, Mark Bensink, et al.. (2018). Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis. Journal of Comparative Effectiveness Research. 7(7). 693–707. 9 indexed citations
7.
Hauber, Brett, et al.. (2017). Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism. BMC Nephrology. 18(1). 254–254. 10 indexed citations
8.
Block, Geoffrey A., Akeem Yusuf, Mark D. Danese, et al.. (2016). Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis. BMC Nephrology. 17(1). 166–166. 4 indexed citations
9.
Brunelli, Steven M., Scott Sibbel, Paul J. Dluzniewski, et al.. (2016). The association between cinacalcet use and missed in‐center hemodialysis treatment rate. Pharmacoepidemiology and Drug Safety. 25(11). 1287–1294. 1 indexed citations
10.
Brunelli, Steven M., Scott Sibbel, Thy P., Kerry Cooper, & Brian D. Bradbury. (2015). Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study. American Journal of Kidney Diseases. 66(4). 655–665. 32 indexed citations
11.
Wetmore, James B., Konstantin Gurevich, Stuart M. Sprague, et al.. (2015). A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM). Clinical Journal of the American Society of Nephrology. 10(6). 1031–1040. 59 indexed citations
12.
Sprague, Stuart M., James B. Wetmore, Konstantin Gurevich, et al.. (2015). Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism. Clinical Journal of the American Society of Nephrology. 10(6). 1021–1030. 58 indexed citations
13.
Brunelli, Steven M., Paul J. Dluzniewski, Kerry Cooper, et al.. (2015). Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation. Pharmacoepidemiology and Drug Safety. 24(10). 1058–1067. 12 indexed citations
14.
Evenepoel, P., Kerry Cooper, Hallvard Holdaas, et al.. (2014). A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism. American Journal of Transplantation. 14(11). 2545–2555. 68 indexed citations
15.
Giles, Michelle, Kerry Cooper, Vicki Parker, et al.. (2013). A fracture prevention service reduces further fractures two years after incident minimal trauma fracture. International Journal of Rheumatic Diseases. 17(2). 195–203. 43 indexed citations
16.
Rodríguez, Mariano, et al.. (2013). Calcium-Mediated Parathyroid Hormone Suppression to Assess Progression of Secondary Hyperparathyroidism During Treatment Among Incident Dialysis Patients. The Journal of Clinical Endocrinology & Metabolism. 98(2). 618–625. 4 indexed citations
17.
18.
Giles, Michelle, et al.. (2010). A team approach: implementing a model of care for preventing osteoporosis related fractures. Osteoporosis International. 22(8). 2321–2328. 23 indexed citations
19.
Gharavi, Ali G., Yan Yan, Francesco Scolari, et al.. (2000). IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23. Nature Genetics. 26(3). 354–357. 218 indexed citations
20.
Bia, Margaret J., et al.. (1989). Aluminum induced anemia: Pathogenesis and treatment in patients on chronic hemodialysis. Kidney International. 36(5). 852–858. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Hory Breakdown of academic impact, for papers by Ana Carina Ferreira Breakdown of academic impact, for papers by Daniela Sardella Breakdown of academic impact, for papers by Carolyn Griffith Breakdown of academic impact, for papers by Lucie Desjardins Breakdown of academic impact, for papers by Kenichi Satomura Breakdown of academic impact, for papers by Ichiro Ohkido Breakdown of academic impact, for papers by Shohei Nakanishi Breakdown of academic impact, for papers by Michael M. Friedlaender Breakdown of academic impact, for papers by Peter Jehle
Rankless by CCL
2026